Career
Our solutions
Contact us
Skip to content
About Carasent
Governance
General meeting
Nomination committee
Board of Directors
Management
Remuneration
Auditors
Articles of association
Investor relations
Annual and quarterly reports
Financial calendar
Other documents
The Share
Share buy-back program
Ownership Structure
Relisting to Nasdaq Stockholm 2024
Why invest in Carasent?
Press releases
Career
Our solutions
Contact us
About Carasent
Governance
General meeting
Nomination committee
Board of Directors
Management
Remuneration
Auditors
Articles of association
Investor relations
Annual and quarterly reports
Financial calendar
Other documents
The Share
Share buy-back program
Ownership Structure
Relisting to Nasdaq Stockholm 2024
Why invest in Carasent?
Press releases
Other Corporate Information
November 21, 2023 - 07:46
Carasent group signs contract to supply Metodika EPM to Volvat Medisinske Senter AS
Read more
November 15, 2023 - 07:00
Carasent ASA – Ex dividend today
Read more
November 14, 2023 - 10:10
Carasent ASA – Minutes from the Extraordinary General Meeting
Read more
November 7, 2023 - 10:02
Carasent ASA – Capital Markets Day presentation
Read more
November 7, 2023 - 08:00
Carasent ASA – announcement of long-term financial targets
Read more
October 23, 2023 - 12:40
Carasent ASA – Invitation to presentation of Q3 2023 results
Read more
October 23, 2023 - 11:45
Carasent ASA – Key information relating to proposed distribution
Read more
October 21, 2023 - 02:00
Carasent ASA – Calling notice for extraordinary general meeting
Read more
October 16, 2023 - 08:23
Carasent ASA – registration link Capital Markets Day
Read more
Load more
